Rocket


News + Filings
Transactions



HALE DAVID F

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/28/2023Oncternal Therapeutics, Inc.GTXIGrantStock Options37.5k$0.36$13.3k 06/28/2023
10/06/2022Dermata Therapeutics, Inc. GrantCommon Stock30.2k$0.00$0 10/06/2022
07/07/2022Dermata Therapeutics, Inc. GrantCommon Stock26.4k$0.00$0 07/07/2022
06/16/2022Oncternal Therapeutics, Inc.GTXIGrantStock Options37.5k$1.08$40.5k 06/16/2022
04/07/2022Dermata Therapeutics, Inc. GrantCommon Stock15.5k$0.00$0 04/07/2022
01/03/2022Dermata Therapeutics, Inc. GrantStock Option (right to buy)5k$1.88$9.4k 01/03/2022
12/09/2021BIOCEPT INCBIOCSaleCommon Stock363$4.06$1.5kBy LLC12/09/2021
12/09/2021BIOCEPT INCBIOCSaleCommon Stock11$4.07$44.8By trust12/09/2021
12/09/2021BIOCEPT INCBIOCSaleCommon Stock71$4.07$288.7 12/09/2021
08/17/2021Dermata Therapeutics, Inc. ConversionCommon Stock44.8k$0.00$0By Hale BioVentures LLC08/17/2021
08/17/2021Dermata Therapeutics, Inc. ConversionCommon Stock12.2k$0.00$0By Hale BioVentures LLC08/17/2021
08/17/2021Dermata Therapeutics, Inc. ConversionCommon Stock20k$0.00$0By Hale BioVentures LLC08/17/2021
08/17/2021Dermata Therapeutics, Inc. ConversionCommon Stock174.2k$0.00$0By Hale BioVentures LLC08/17/2021
08/17/2021Dermata Therapeutics, Inc. ConversionCommon Stock27.1k$0.00$0By Hale BioVentures LLC08/17/2021
08/17/2021Dermata Therapeutics, Inc. PurchaseCommon Stock35.7k$0.00$0By Hale Family Trust08/17/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1d Preferred Stock302.1k$0.00$0By Hale BioVentures LLC08/17/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1a Preferred Stock250k$0.00$0By Hale BioVentures LLC08/17/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1b Preferred Stock410k$0.00$0By Hale BioVentures LLC08/17/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1c Preferred Stock3.6M$0.00$0By Hale BioVentures LLC08/17/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1 Preferred Stock555.6k$0.00$0By Hale BioVentures LLC08/17/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1a Warrants62.5k$0.00$0By Hale BioVentures LLC08/17/2021
08/17/2021Dermata Therapeutics, Inc. ConversionWarrant to Purchase Common Stock3k$20.50$62.5kBy Hale BioVentures LLC08/17/2021
08/17/2021Dermata Therapeutics, Inc. PurchaseWarrant to Purchase Common Stock35.7k$7.00$250kBy Hale Family Trust08/17/2021
07/16/2021BIOCEPT INCBIOCGrantEmployee Stock Option (right to buy)10k$3.77$37.7k 07/16/2021
06/30/2021Oncternal Therapeutics, Inc.GTXISaleCommon Stock3.7k$4.75$17.4kBy Hale BioPharma Ventures, LLC06/30/2021
05/25/2021Oncternal Therapeutics, Inc.GTXIGrantStock Options37.5k$5.14$192.8k 05/25/2021
06/12/2020BIOCEPT INCBIOCSaleCommon Stock159$0.56$88.7By LLC06/12/2020
06/12/2020BIOCEPT INCBIOCSaleCommon Stock445$0.55$246.8By trust06/12/2020
06/12/2020BIOCEPT INCBIOCSaleCommon Stock556$0.56$308.6 06/12/2020
06/11/2020Oncternal Therapeutics, Inc.GTXIGrantStock Options22.5k$2.94$66.2k 06/11/2020
06/11/2020Oncternal Therapeutics, Inc.GTXIGrantStock Option22.5k$2.94$66.2k 06/11/2020
06/05/2020BIOCEPT INCBIOCGrantEmployee Stock Option (right to buy)500$0.48$239.8 06/05/2020
05/21/2020Oncternal Therapeutics, Inc.GTXIPurchaseCommon Stock17.4k$0.00$0By Hale BioPharma Ventures LLC05/21/2020
05/21/2020Oncternal Therapeutics, Inc.GTXIPurchaseWarrants8.7k$2.51$21.9kBy Hale BioPharma Ventures LLC05/21/2020
09/12/2019Oncternal Therapeutics, Inc.GTXIGrantStock Option40k$5.76$230.4k 09/12/2019
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy